Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure

Author: Mayer-Sonnenfeld Tehila   Har-Noy Michael   Lillehei Kevin O.   Graner Michael W.  

Publisher: Informa Healthcare

ISSN: 1464-5157

Source: International Journal of Hyperthermia, Vol.29, Iss.6, 2013-09, pp. : 520-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content